Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 4 studies | 20% ± 5% | |
glutamatergic neuron | 4 studies | 42% ± 21% | |
plasmacytoid dendritic cell | 4 studies | 20% ± 2% | |
non-classical monocyte | 3 studies | 20% ± 4% | |
endothelial cell | 3 studies | 19% ± 3% | |
epithelial cell | 3 studies | 19% ± 1% | |
GABAergic neuron | 3 studies | 39% ± 12% | |
oligodendrocyte precursor cell | 3 studies | 19% ± 1% | |
interneuron | 3 studies | 27% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 34% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1730.87 | 180 / 180 | 100% | 25.98 | 430 / 430 |
thymus | 100% | 2997.28 | 653 / 653 | 100% | 30.20 | 605 / 605 |
brain | 100% | 3094.87 | 2641 / 2642 | 100% | 51.17 | 705 / 705 |
adrenal gland | 100% | 2848.42 | 258 / 258 | 100% | 48.38 | 229 / 230 |
esophagus | 100% | 1715.59 | 1445 / 1445 | 99% | 18.18 | 182 / 183 |
pancreas | 100% | 1575.30 | 328 / 328 | 99% | 23.52 | 177 / 178 |
prostate | 100% | 2812.32 | 245 / 245 | 99% | 35.74 | 499 / 502 |
liver | 100% | 2212.94 | 226 / 226 | 99% | 22.23 | 403 / 406 |
kidney | 100% | 1854.60 | 89 / 89 | 99% | 18.83 | 893 / 901 |
skin | 100% | 1799.52 | 1809 / 1809 | 99% | 24.80 | 467 / 472 |
uterus | 100% | 2133.18 | 170 / 170 | 99% | 20.59 | 454 / 459 |
intestine | 100% | 2057.18 | 966 / 966 | 99% | 16.88 | 521 / 527 |
stomach | 100% | 1727.33 | 359 / 359 | 99% | 17.01 | 282 / 286 |
breast | 100% | 2294.00 | 459 / 459 | 98% | 22.85 | 1100 / 1118 |
lung | 100% | 2279.60 | 577 / 578 | 98% | 18.90 | 1136 / 1155 |
bladder | 100% | 1935.67 | 21 / 21 | 97% | 19.96 | 487 / 504 |
adipose | 100% | 1979.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 28.45 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.70 | 29 / 29 |
spleen | 100% | 4287.97 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.70 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.08 | 1 / 1 |
blood vessel | 100% | 1539.06 | 1329 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1259.39 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1993.69 | 912 / 929 | 0% | 0 | 0 / 0 |
muscle | 98% | 1076.64 | 783 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0070050 | Biological process | neuron cellular homeostasis |
GO_0035751 | Biological process | regulation of lysosomal lumen pH |
GO_0090385 | Biological process | phagosome-lysosome fusion |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0035752 | Biological process | lysosomal lumen pH elevation |
GO_0010008 | Cellular component | endosome membrane |
GO_0005764 | Cellular component | lysosome |
GO_0005768 | Cellular component | endosome |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005267 | Molecular function | potassium channel activity |
GO_0050544 | Molecular function | arachidonic acid binding |
GO_0015252 | Molecular function | proton channel activity |
GO_0022841 | Molecular function | potassium ion leak channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TMEM175 |
Protein name | Transmembrane protein 175 Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175) Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175) (hTMEM175) |
Synonyms | MGC4618 hCG_34455 |
Description | FUNCTION: Proton-activated proton channel that catalyzes proton efflux from endosomes and lysosomes to maintain a steady-state pH . Activated at low pH (under pH 4.6) by luminal side protons: selectively mediates lysosomal proton release from lysosomes, eliciting a proton leak that balances V-ATPase activity to maintain pH homeostasis . Regulation of lumenal pH stability is required for autophagosome-lysosome fusion . Also acts as a potassium channel at higher pH, regulating potassium conductance in endosomes and lysosomes . Constitutes the pore-forming subunit of the lysoK(GF) complex, a complex activated by extracellular growth factors . The lysoK(GF) complex is composed of TMEM175 and AKT (AKT1, AKT2 or AKT3), a major target of growth factor receptors: in the complex, TMEM175 channel is opened by conformational changes by AKT, leading to its activation . The lysoK(GF) complex is required to protect neurons against stress-induced damage . . |
Accessions | D6RAJ5 ENST00000514546.5 ENST00000515492.5 ENST00000264771.9 [Q9BSA9-1] ENST00000514453.5 ENST00000507319.5 ENST00000622959.3 [Q9BSA9-2] D6RHV8 ENST00000513682.5 ENST00000509508.5 F6UWG6 Q9BSA9 D6RDY8 ENST00000510493.5 ENST00000508204.5 ENST00000513952.5 D6RCD9 ENST00000515740.5 [Q9BSA9-2] D6RIZ2 ENST00000504744.5 D6RBE5 D6RAU7 E7ETE6 |